Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes

个性化综合肿瘤学：实现最佳结果的针对性方法

• 批准号: 8838465
• 负责人: Lorenzo Cohen
• 金额: $ 0.8万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-01 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8838465
• 关键词: Academy; Address; Advocate; Affect; American; Area; Basic Science; British Columbia; Canada; Case Study; Clinical; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Communities; Data; Development; Educational workshop; Epigenetic Process; Fostering; Future; Growth; Guidelines; Health Professional; Healthcare; Institution; Integrative Medicine; International; Joints; Knowledge; Learning; Life Style; Malignant Neoplasms; Oncologist; Oral; Outcome; Palliative Medicine; Patient Care; Patient advocacy; Patients; Prevention; Recording of previous events; Recovery; Research; Research Methodology; Research Personnel; Role; Sleep Disorders; Societies; Stream; Stress; Targeted Research; Technology; Texas; Therapeutic; Time; Training; United States; Universities; University of Texas M D Anderson Cancer Center; Work; base; career; clinical practice; dissemination research; evidence base; experience; hospice environment; improved; innovation; knowledge translation; lectures; malignant breast neoplasm; meetings; member; mindfulness; multidisciplinary; next generation; oncology; posters; programs; public health relevance; stem; symposium; symptom management; tumor

DESCRIPTION (provided by applicant): The Society for Integrative Oncology (SIO) 11th International Conference, entitled "Personalized Integrative Oncology: Targeted Approach For Optimal Outcomes", aims to critically examine recent advances in research that have the potential to improve the practice of integrative oncology as a contemporary health care option. This conference will focus on disseminating important findings from integrative oncology research that are taking a targeted approach including both basic and clinical science, to ultimately improve the outcome of patient care. The overarching aim of the SIO 2014 conference is to highlight the unique trajectory of targeted integrative oncology research, knowledge development, and its implication in integrative oncology. The 2 and 1/2-day meeting is being held in Houston and is co-hosted by the University of Texas MD Anderson Cancer Center. The 2014 SIO conference program contains three keynote lectures that will directly address current research in targeted integrated oncology including the: 1) The role of personalized integrative oncology in the prevention, treatment and recovery from cancer; 2) The impact of stress on patients with cancer; and 3) The intersection of sleep disorders and cancer. In addition to keynote lectures, the conference will include: four moderated plenary panels are planned covering: 1) personalized integrative oncology; 2) the role of lifestyle and epigenetics in the context of cancer; 3) a joint session with AAHPM to tackle targeted symptom management; and 4) breast cancer guidelines. The conference will also have two multidisciplinary integrative tumor boards; two preconference workshops to focus on clinical research and clinical practice relevant to innovated integrative oncology; four didactic and experiential workshops; a public lecture on mindfulness practices in integrative oncology; and patient advocacy and trainee streams. Presentations of original research, in various topics related to targeted integrated oncology, including clinical trials, basic science, and research methodology, will be solicited from members of the national and international research communities for 45 oral and up to 80 poster presentations. The conference aims are to: 1) Create an international venue in which researchers, clinicians and patient advocates can discuss the current evidence regarding targeted integrative oncology research and practices and enhance their understanding the advantage and challenge of this particular field; 2) Foster dialogue, collaboration and networking among researchers, health professionals, and patient advocates, facilitating future research and knowledge using targeted strategies in the field of integrative oncology; and 3) Assist in the training of trainees, early career investigators and patient advocates in creating, interpreting an disseminating evidence-based integrative oncology research. Ultimately, it is our hope that the renewed knowledge and clinical practice on targeted integrative oncology obtained from this conference will improve the outcome of patient care by integrative oncologist and practitioners.

描述（由申请人提供）：综合肿瘤学会（SIO）第11届国际会议，题为“个性化综合肿瘤学：最佳结果的有针对性方法”，旨在批判性地研究研究进展的最新进展，这些进步有可能改善综合肿瘤学实践作为当代医疗保健选择。这次会议将着重于传播综合肿瘤学研究的重要发现，这些发现正在采用针对性的方法，包括基础科学和临床科学，以最终改善患者护理的结果。 SIO 2014会议的总体目的是突出有针对性的综合肿瘤研究，知识发展及其对综合肿瘤学的影响的独特轨迹。 为期2天和1/2天的会议将在休斯敦举行，由德克萨斯大学医学博士安德森癌症中心共同主持。 2014年SIO会议计划包含三个主题演讲，这些讲座将直接解决针对性综合肿瘤学的当前研究，包括：1）个性化综合肿瘤学在预防，治疗和从癌症中恢复中的作用； 2）压力对癌症患者的影响； 3）睡眠障碍与癌症的交集。除主题演讲外，会议还将包括：四个主持的全体会议计划涵盖：1）个性化综合肿瘤学； 2）生活方式和表观遗传学在 癌症的背景； 3）与AAHPM的联合会议，以应对有针对性的症状管理； 4）乳腺癌指南。会议还将有两个多学科的综合肿瘤委员会；两个与创新综合肿瘤学相关的临床研究和临床实践的临床研究和临床实践的研讨会；四个教学和体验式研讨会；关于综合肿瘤学的正念实践的公开演讲；以及患者的倡导和学员流。原始研究的介绍，与有针对性的综合肿瘤学有关的各种主题，包括临床试验，基础科学和研究方法论，将由国家和国际研究社区成员征求45个口头和多达80张海报演讲。会议的目的是：1）创建一个国际场所，研究人员，临床医生和患者倡导者可以讨论有关目标综合肿瘤学研究和实践的当前证据，并增强他们对该特定领域的优势和挑战的理解； 2）研究人员，卫生专业人员和患者倡导者之间的对话，协作和网络，以综合肿瘤学领域的有针对性策略来促进未来的研究和知识； 3）协助培训受训者，早期职业研究者和患者倡导者创建，解释传播基于证据的综合肿瘤学研究。最终，我们希望从本次会议获得的针对性综合肿瘤学的新知识和临床实践将改善综合肿瘤学家和从业者的患者护理结果。

项目成果

Personalized integrative oncology: targeted approaches for optimal outcomes: the 11th International Conference of the Society for Integrative Oncology.

个性化综合肿瘤学：最佳结果的针对性方法：第 11 届综合肿瘤学学会国际会议。

• DOI: 10.1177/1534735414563603
• 发表时间: 2015
• 期刊: Integrative cancer therapies
• 影响因子: 2.9
• 作者: Lee,RichardT;Yang,Peiying;Greenlee,Heather;Bauer-Wu,Susan;Balneaves,LyndaG;Zick,Suzanna
• 通讯作者: Zick,Suzanna